Strategic Enablement Ximedica is now part of Veranex, positioning the company to offer an expanded, end-to-end product development platform across design, engineering, regulatory, clinical, and market access. This presents cross-sell opportunities to clients seeking integrated solutions from concept to commercialization.

Healthcare Focus Operating in medical equipment manufacturing with a regional team size of 51-200 employees, Ximedica targets healthcare innovators and device manufacturers—ideal fits for customers needing specialized medical device development and regulatory support.

Proven Partnerships Past collaborations with Boston Scientific, 3Derm Systems, and VitaHEAT Medical demonstrate a track record of co-developing devices and bringing advanced technology to market, signaling credibility and a pathway for new clients seeking similar acceleration.

Market Validation Recognition by Insight Success as a top pharma/biotech solution provider and ongoing involvement with MedTech Innovator highlight industry validation, which can be leveraged in outreach to prospective customers seeking trusted development partners.

Growth Signals Revenue range of 25–50 million and affiliation with Veranex imply scale and resource depth for larger engagements, enabling conversations about expanded program scope, regulatory strategy, clinical evaluation, and market access services.